Literature DB >> 32639481

Sustaining tuberculosis preventive therapy scale-up through direct supportive supervision.

S C Meribe1, Y Adamu1, E Adebayo-Abikoye1,2, I Lawal1, I Amazue-Ezeuko1,2, N Okeji3, I Okoye1, P Agaba4,5, R Nelson1, E Lee4, L Chittenden1.   

Abstract

BACKGROUND: Tuberculosis preventive therapy (TPT) is recommended for tuberculosis (TB) prevention among people living with HIV (PLHIV) and other high-risk groups. The Nigerian Military HIV Program embarked on TPT-specific 'direct supportive supervision' (DSS) in May 2018 to increase TPT initiation and completion rates.
METHODS: Interventional approaches included site visits to conduct root cause analysis, didactic teaching approach on the concepts of quality improvement and mentorship to address barriers. The DSS introduced TPT monitoring tools, sticker reminders on clients' folders, and bi-weekly data collection and review for decision making.
RESULTS: TPT initiation increased from a monthly pre-intervention median of 323 clients to monthly medians of 2611 during the 'surge' and 1212 clients during the 'sustained' phases. Due to an isoniazid stock-out, a 'dip phase', with a median of 559 clients was recorded. Overall, 10 463 clients were started on TPT in fiscal year (FY) 2018 and 12 596 in FY2019, with an overall initiation rate of 79%. Completion rates were respectively 73% and 70% for FY2018 and FY2019.
CONCLUSION: With the implementation of a tailored DSS, programmatic barriers to TPT were easily identified and quickly addressed to increase initiation and completion rates.
© 2020 The Union.

Entities:  

Keywords:  TPT; isoniazid; people living with HIV; tuberculosis

Year:  2020        PMID: 32639481      PMCID: PMC7316438          DOI: 10.5588/pha.20.0003

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  8 in total

1.  Reducing stock-outs of essential tuberculosis medicines: a system dynamics modelling approach to supply chain management.

Authors:  L Bam; Z M McLaren; E Coetzee; K H von Leipzig
Journal:  Health Policy Plan       Date:  2017-10-01       Impact factor: 3.344

2.  Severe cutaneous adverse reactions due to isoniazid in a HIV positive patient.

Authors:  B K Viswanath; P Ranka; M Ramanjanayalu
Journal:  Indian J Lepr       Date:  2012 Jul-Sep

Review 3.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 4.  HIV infection-associated tuberculosis: the epidemiology and the response.

Authors:  Haileyesus Getahun; Christian Gunneberg; Reuben Granich; Paul Nunn
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

5.  Taking tuberculosis preventive therapy implementation to national scale: the Nigerian PEPFAR Program experience.

Authors:  B Odume; S C Meribe; T Odusote; M Ifunanya; H Debem; I Amazue-Ezeuko; O Ogbanufe; Y Adamu; D Onotu
Journal:  Public Health Action       Date:  2020-03-21

6.  Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets - 2017.

Authors:  Adam MacNeil; Philippe Glaziou; Charalambos Sismanidis; Susan Maloney; Katherine Floyd
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-03-22       Impact factor: 17.586

7.  Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.

Authors:  Gebrehiwot Teklay; Tsigemariam Teklu; Befikadu Legesse; Kiros Tedla; Eveline Klinkenberg
Journal:  BMC Public Health       Date:  2016-08-19       Impact factor: 3.295

Review 8.  Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis.

Authors:  Rishi K Gupta; Sebastian B Lucas; Katherine L Fielding; Stephen D Lawn
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

  8 in total
  3 in total

1.  Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019.

Authors:  Andrew T Boyd; Bethrand Odume; Kassim Sidibe; Dennis Onotu; Obinna Ogbanufe; Ifunanya Mgbakor; Mahesh Swaminathan
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-01       Impact factor: 3.771

2.  Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid-Preventive therapies for people living with HIV.

Authors:  Pia Müller; Luís Velez Lapão
Journal:  PLoS One       Date:  2022-03-01       Impact factor: 3.240

3.  Attaining 95-95-95 through Implementation Science: 15 Years of Insights and Best Practices from the Walter Reed Army Institute of Research's Implementation of the U.S. President's Emergency Plan for AIDS Relief.

Authors:  Elizabeth H Lee; Kavitha Ganesan; Samoel A Khamadi; Stanley C Meribe; Dorothy Njeru; Yakubu Adamu; Fred Magala; Trevor A Crowell; Eniko Akom; Patricia Agaba; Priyanka Desai; Tiffany Hamm; Deydre Teyhen; Julie A Ake; Christina S Polyak; Douglas Shaffer; Fredrick Sawe; Patrick W Hickey
Journal:  Am J Trop Med Hyg       Date:  2021-01       Impact factor: 3.707

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.